Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Costs of taxanes, capecitabine, quantified for breast cancer

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Costs of taxanes, capecitabine, quantified for breast cancer. Pharmacoecon. Outcomes News 595, 1 (2010). https://doi.org/10.2165/00151234-201005950-00001

    Download citation

    Keywords

    • Breast Cancer
    • Docetaxel
    • Capecitabine
    • Taxane
    • Medical Claim